Physician profile
Patrick John Geml
NPI 1770555062
$16,609.93
in general payments reported to CMS, 2019-2025
57 companies · $3,688 in 2025
The $3,688 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,881 · 2022: $3,442 · 2023: $2,921 · 2024: $3,677 · 2025: $3,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $43.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,242.91 |
| Education | $43.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,475.48 | 2021-2025 | |
| Ucb, INC. | $1,458.58 | 2021-2025 | Nayzilam, Fintepla, Rystiggo |
| Novartis Pharmaceuticals Corporation | $1,265.43 | 2021-2025 | |
| Biogen, INC. | $1,217.58 | 2021-2025 | Vumerity, Tysabri, Avonex |
| Nalu Medical, INC. | $962.65 | 2022-2024 | Nalu Neurostimulation System |
| Sk Life Science, INC. | $760.22 | 2021-2025 | |
| Emd Serono, INC. | $714.22 | 2021-2025 | Mavenclad |
| Eisai INC. | $590.92 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $561.37 | 2022-2025 | Purified Cortrophin Gel |
| Pfizer INC. | $517.06 | 2022-2025 | |
| Lundbeck LLC | $513.21 | 2021-2025 | Vyepti, Rexulti |
| Amgen INC. | $499.05 | 2021-2025 | Uplizna |
| Celgene Corporation | $497.16 | 2021-2025 | Zeposia |
| Genentech USA, INC. | $419.52 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Horizon Therapeutics Plc | $394.98 | 2021-2023 | Uplizna |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Geml listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.